Publications by authors named "J Braden"
Article Synopsis
- A new technique using microwave plasma-atomic emission spectrometry (MP-AES) was created to analyze essential and trace minerals in cereals, pseudocereals, and legumes.
- The method was tested and validated with certified reference materials from various crops like durum wheat, corn bran, quinoa, rice, and soy, showing good accuracy in mineral content recovery.
- This method allows plant breeders to enhance and evaluate crops for better nutrient density, which can improve food quality.
Climate change increases stressors that will challenge the resiliency of global agricultural production. Just three crops, wheat, maize, and rice, are estimated to sustain 50% of the caloric demand of the world population, meaning that significant loss of any of these crops would threaten global food security. However, increasing cropping system diversity can create a more resilient food system.
View Article and Find Full Text PDFArticle Synopsis
- The study examines the effectiveness of combining anti-PD-1 and anti-CTLA-4 therapies compared to anti-PD-1 alone for advanced melanoma patients with liver metastases.
- Results showed a higher objective response rate in the combination therapy group (47%) versus anti-PD-1 monotherapy (35%), though no significant differences were found in progression-free or overall survival rates.
- The study concludes that combination therapy may offer better treatment responses, suggesting it should be considered for patients with liver metastases in future treatment plans.
Recent psychological research suggests that many published studies cannot be replicated (e.g., Open Science Collaboration, 2015).
View Article and Find Full Text PDFImportance: Evolving evidence suggests that patients receiving Janus kinase-signal transducer and activator of transcription inhibitors (JAK-STATi) may be at higher risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). Most existing literature has focused on indications that may confer a higher MACE and VTE risk than that among patients with isolated dermatological indications.
Objective: To evaluate risk of MACE, VTE, serious adverse events (SAEs), and tolerability of systemic JAK-STATi compared with placebo, in those with a dermatologic indication.